Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Osaka University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osaka University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Osaka University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osaka University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Osaka University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Osaka University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Mitsubishi Tanabe Pharma and Osaka University Enter into Agreement 11
KAN Research Institute Enters into Development Agreement with Six Research Organizations 12
Mitsubishi Tanabe Pharma Forms Joint Venture with Research Foundation for Microbial Diseases of Osaka University 14
Oncolys Biopharma Enters into Research Agreement with Osaka University 15
BIKEN Enters into Distribution Agreement with Chiba Prefectural Institute of Health 16
Chugai Pharmaceutical Enters into Agreement with Osaka University 17
Takeda Pharma Enters Into Co-Marketing Agreement With Research Foundation For Microbial Diseases Of Osaka University 18
Takeda Pharma Enters Into Research Agreement With Osaka University 19
Licensing Agreements 20
Japan Agency for Medical Research and Development Enters into Licensing Agreement with Osaka University 20
NobelPharma Enters into Licensing Agreement with Osaka University 21
BIKEN Enters into Licensing Agreement with Osaka University 22
FunPep Enters into Licensing Agreement with Osaka University 23
Osaka University – Key Competitors 24
Osaka University – Key Employees 25
Osaka University – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Government and Public Interest 28
Aug 09, 2018: Anticancer drugs delivered by a new drug delivery system reduce tumor size 28
May 30, 2018: Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research 29
Apr 18, 2018: Researchers uncover origin of virus-fighting plasma B cells 30
Dec 20, 2017: CD4 T Cells, Xenobiotic Transporters, and Metabolites in Inflammatory Bowel Diseases 31
Nov 07, 2017: Osaka University: New Strategy for Multiple Myeloma Immunotherapy 32
Oct 26, 2017: Successful Cardiogenic Shock Treatment Using a Percutaneous Left Ventricular Assist Device 33
Sep 15, 2017: Novel Small Antibody Fragment: A Valuable Tool in Crystallography 34
Aug 22, 2017: The Pancreas provides a potential drug candidate for brain disease 35
Product News 36
Oct 29, 2018: Experimental vaccine may reduce post-stroke blood clot risk 36
Mar 26, 2018: New Breakthrough in Treatment for Rare Skin Condition 37
Other Significant Developments 38
Jul 02, 2018: Mitsubishi Tanabe Pharma and Osaka University co-found the “Department of Neuro-Medical Science” 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
Osaka University, Pharmaceuticals & Healthcare, Key Facts 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osaka University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Osaka University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osaka University, Deals By Therapy Area, 2012 to YTD 2018 8
Osaka University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mitsubishi Tanabe Pharma and Osaka University Enter into Agreement 11
KAN Research Institute Enters into Development Agreement with Six Research Organizations 12
Mitsubishi Tanabe Pharma Forms Joint Venture with Research Foundation for Microbial Diseases of Osaka University 14
Oncolys Biopharma Enters into Research Agreement with Osaka University 15
BIKEN Enters into Distribution Agreement with Chiba Prefectural Institute of Health 16
Chugai Pharmaceutical Enters into Agreement with Osaka University 17
Takeda Pharma Enters Into Co-Marketing Agreement With Research Foundation For Microbial Diseases Of Osaka University 18
Takeda Pharma Enters Into Research Agreement With Osaka University 19
Japan Agency for Medical Research and Development Enters into Licensing Agreement with Osaka University 20
NobelPharma Enters into Licensing Agreement with Osaka University 21
BIKEN Enters into Licensing Agreement with Osaka University 22
FunPep Enters into Licensing Agreement with Osaka University 23
Osaka University, Key Competitors 24
Osaka University, Key Employees 25
Osaka University, Other Locations 26
Osaka University, Subsidiaries 26
List of Figures
Osaka University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osaka University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Osaka University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osaka University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8